Jon Linden Photo

Industry Experience

Senior Counsel

Millennium Pharmaceuticals, Inc. (now Takeda Pharmaceutical Company Limited)

Deputy General Counsel

Brookstone, Inc.

Product Counsel

Apple, Inc.

Jon skillfully handles complex transactions and agreements in the life sciences and technology industries. He guides life sciences clients through research and development, as well as manufacturing. He also helps his clients negotiate effective product licensing transactions with other commercial entities and academic research institutions. Jon’s considerable experience also includes trans-border deals, where he has negotiated and successfully completed product licenses involving European, Asian and U.S-based drug companies, including related supply agreements.

He also advises technology clients on complex software license and related support agreements, as well as IT platform license and support agreements for drug development, healthcare services, database services and other applications.


experience +

experience –

Millennium Pharmaceuticals, Inc. (now Takeda Pharmaceutical Company Limited)

Senior Counsel

  • Handled legal matters for the company in many areas, including licensing biotechnology and software
    technologies and advising its clinical and manufacturing operations
  • Primary business attorney for one of Millennium’s key technology alliances
  • Helped to mentor and train contracts associates

Brookstone

Deputy General Counsel

  • Helped develop systems for intellectual property protection for the company’s proprietary products

Apple

Software and technical counsel

  • Provided legal counsel for a variety of Apple product lines

Folger & Levin

Business Associate

  • Several years of publishing industry experience

Recent Client Work +

Recent Client WOrk –

  • Collaboration agreement between Biogen and Proteostasis Therapeutics, Inc., for the development of drugs to combat Alzheimer’s and other neurodegenerative diseases (involved amendment of a pre-existing license agreement with Harvard University)
  • In-license of antibody screening and development platform by Biogen from Adimab, LLC
  • License and collaboration agreement between Taiwanese company PharmaEngine, Inc. and Merrimack Pharmaceuticals, Inc. (now Ipsen Pharma) involving grant back from PharmaEngine to Merrimack of research, development and commercialization rights to an oncology drug candidate in exchange for milestones and royalties
  • Exclusive in-license by Taiwanese company PharmaEngine, Inc. from French company Nanobiotix, S.A. of Asian research, development and commercialization rights to nanotherapy oncology treatment
  • Expansion from Asia-only to worldwide of Japanese company Solasia Pharma K.K.’s exclusive license with ZIOPHARM Oncology, Inc. for research, development and commercialization of oncology product
  • Exclusive in-license by Corbus Pharmaceuticals Holdings, Inc. from Jenrin Discovery LLC of exclusive worldwide rights to more than 600 compounds targeting the endocannabinoid system
  • Supervision of Faber’s clinical trial contracting efforts for Portola Pharmaceuticals, Inc., including Portola’s approved products Bevixxa® (betrixaban) and Andexxa® (coagulation factor Xa (recombinant), inactivated-zhzo)
  • Amendment of existing agreement between Arsanis, Inc. and Adimab, LLC (involved coordination with a grant agreement with the Bill & Melinda Gates Foundation)
  • Review and negotiation of numerous agreements for provision of genetic testing and analysis services for client Personalis, Inc.


Community +

Community –

Joe is or has been involved in a wide range of philanthropic and community organizations, including:

  • The Center for Discovery. Pro bono counsel for R&D initiatives at a leading provider of medical and clinical care and education services for people with complex developmental disabilities.
  • Dana-Farber Cancer Institute and Partners in Health. Pro bono counsel for an international health services joint venture.
  • Center for Maine Contemporary Art, Board of DirectorsTrustees.
  • Partners Healthcare Center for Personalized Genetic Medicine, Genetics Advisory Council, past member.
  • Columbia University’s College of Physicians and Surgeons, Medical Science and Technology Council, past member.
  • CAVU Foundation, Board of Directors, past member. CAVU  supported community programs that enhance the health care of underserved children in Massachusetts.
  • Venturing Out, Board of Directors, past member. Venturing Out was an innovative not-for-profit organization that taught entrepreneurship to incarcerated and court-involved adults and high-risk youth.
  • The Possible Project, Co-Founder of a not-for-profit that helps young people imagine, create and run their own business.
  • Slow Money, Maine and New York chapters. Joe worked with leadership to create pathways for individuals and families to provide financial assistance to farmers and agriculture businesses promoting sustainable local food systems. He also developed novel “patient loan” structures that have been used to raise critical financing for businesses that are re-building agricultural and fisheries food infrastructures.

Joe has spoken on business law and ethics at the Massachusetts Institute of Technology (Program of Health Sciences and Technology), Ross School of Business at the University of Michigan (Net Impact Conference), and Boston College Law School.

Joe was a member of the National Finance Council and actively involved in the voter protection team for the Stacey Abrams for Governor campaign.

Bar Admissions
  • ‍California
  • Massachusetts
Education
  • Stanford Law School, J.D.,  with Distinction
  • Brown University, A.B., magna cum laude with Honors